Intersect ENT (XENT) Tops Q1 EPS by 10c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Intersect ENT (XENT) Tops Q1 EPS by 10c

Intersect ENT Reports First Quarter 2015 Results

May 6, 2015 4:02 PM EDT

Revenue Increased 78% Year Over Year to $13.4 Million

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the first quarter ended March 31, 2015.

Recent Highlights

Achieved revenue growth of 78% over Q1 2014. Realized gross margin of 79% versus 69% in Q1 2014. Patient enrollment for both the RESOLVE II study and the PROGRESS study... More